Article Details

FDA approves insulin-aspart-szjj as biosimilar for diabetes treatment

Retrieved on: 2025-02-14 21:20:05

Tags for this article:

Click the tags to see associated articles and topics

FDA approves insulin-aspart-szjj as biosimilar for diabetes treatment. View article details on hiswai:

Excerpt

The FDA has approved the first rapid-acting insulin biosimilar product for the treatment of diabetes, according to a press release from the ...

Article found on: www.contemporarypediatrics.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up